Hikal: Successfully developed Fapiravir APIs and intermediates
Indian pharmaceutical intermediate and API manufacturer Hikal Limited (Hikal Limited) announced on June 19 that it has successfully developed Favipiravir API and its intermediates.
Fapiravir is a generic drug of Avigan, a drug of Toyama Chemical, a subsidiary of Fujifilm Corporation in Japan. The drug has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of new influenza virus infections. At present, in many countries, piravir is in different stages of clinical trials for the treatment of new coronavirus pneumonia.
It is reported that Hikal is negotiating with potential partners on the supply of the finished medicine.
You May Interested In
High Quality β-Nicotinamide adenine dinucleotide CAS 53-84-9 NADwith ready stock and best price
$3/UNIT FOB
2026-10-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Launches Concentrated Anti-Dumping Actions Against Eight Categories of Chinese Chemicals, Covering APIs/Intermediates, Polyurethanes, and Refrigerants
-
GLP-1 API Route to U.S. Abruptly Narrows: FDA Heavily Penalizes U.S. Compounding Pharmacy and Bypasses Warning Letter to Ban Chinese Factory
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
CPHI & PMEC India 2026
-
Three Major Indian Chemical Investments Target China's PC Exports
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
India Extends Anti-Dumping Duties on Aniline Imports from China for Five More Years
-
Covestro India and CSIR-NCL Collaborate to Transform Polyurethane Waste
Recommend Reading
-
![]()
"No available slots" returns as global shipping rates skyrocket amid multiple factors
-
![Middle East Crude Exports Rebound Sharply in September as Saudi Arabia Returns to Market at 5.4 Million bpd]()
Middle East Crude Exports Rebound Sharply in September as Saudi Arabia Returns to Market at 5.4 Million bpd
-
![Chevron Opens Oilfield Chemical Technology to Rivals]()
Chevron Opens Oilfield Chemical Technology to Rivals
-
![Retinol in Cosmetics: Regulatory Tightening and Market Changes]()
Retinol in Cosmetics: Regulatory Tightening and Market Changes
-
![This Is Not a Price Increase Wave but a Full-Blown Cost Squeeze Across China’s Coatings Chain]()
This Is Not a Price Increase Wave but a Full-Blown Cost Squeeze Across China’s Coatings Chain
-
![关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances]()
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
![Rate of Change Remains Positive—Retail Prices for Refined Oil Products Are Set to Rise in This Round]()
Rate of Change Remains Positive—Retail Prices for Refined Oil Products Are Set to Rise in This Round
-
![Business Society October 13, 2026 Isooctanol Trend Analysis: Uptrend Confirmed]()
Business Society October 13, 2026 Isooctanol Trend Analysis: Uptrend Confirmed
-
![Rubber Cement: Applications and Safety Guidelines]()
Rubber Cement: Applications and Safety Guidelines
-
![Supply-side factors push up formic acid prices, but insufficient demand halts the upward trend]()
Supply-side factors push up formic acid prices, but insufficient demand halts the upward trend
